Daily Archives: October 26, 2006

How to finance drug development

The news today that AstraZeneca failed to meet phase III trials for its stroke drug NXY-059 has prompted Tim Worstall to ask opponents of drug patents If AstraZeneca is not allowed to make fat profits from those drugs that do … Continue reading

Share
Posted in Business economics | 4 Comments

Unusual preferences v madness?

Bryan Caplan has written a thought provoking paper building on Thomas Szasz‘s work to argue that most mental illness can be seen as unusual preferences rather than having a medical or pathological basis. We should not, he says, be surprised … Continue reading

Share
Posted in Madness and Preferences | 1 Comment